Association between Genetic Variants in Pre-MicroRNAs and Survival of Early-Stage NSCLC  Mi Jeong Hong, MS, Yi Young Choi, MS, Ji-Ae Jang, MS, Hye-Jin.

Slides:



Advertisements
Similar presentations
The Accuracy of Frozen Section Diagnosis of Pulmonary Nodules: Evaluation of Inflation Method during Intraoperative Pathology Consultation with Cryosection.
Advertisements

Clinical Significance of IGFBP-3 Methylation in Patients with Early Stage Gastric Cancer  Seung Tae Kim, Hye-Lim Jang, Jeeyun Lee, Se Hoon Park, Young.
Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,
Volume 150, Issue 6, Pages (December 2016)
Who Are Less Likely to Receive Subsequent Chemotherapy Beyond First-Line Therapy for Advanced Non-small Cell Lung Cancer?: Implications for Selection.
The Signature from Messenger RNA Expression Profiling Can Predict Lymph Node Metastasis with High Accuracy for Non-small Cell Lung Cancer  Naeyun Choi,
Improved Outcome of a Reduced Toxicity-Fludarabine, Cyclophosphamide, plus Antithymocyte Globulin Conditioning Regimen for Unrelated Donor Transplantation.
Features of Gastric Carcinoma With Lymphoid Stroma Associated With Epstein-Barr Virus  Hyun Lim, Young Soo Park, Jeong Hoon Lee, Da Hye Son, Ji Yong Ahn,
Who Are Less Likely to Receive Subsequent Chemotherapy Beyond First-Line Therapy for Advanced Non-small Cell Lung Cancer?: Implications for Selection.
Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection  Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.
Coronary Computed Tomography Angiography for Selecting Coronary Artery Bypass Graft Surgery Candidates  Soo-Yeon Kim, MD, Hye-Jeong Lee, MD, PhD, Young.
Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.
Prognostic Significance of PD-L1 in Patients with Non–Small Cell Lung Cancer: A Large Cohort Study of Surgically Resected Cases  Jong-Mu Sun, MD, Wei.
Long-term outcomes of percutaneous mitral balloon valvuloplasty versus open cardiac surgery  Jae-Kwan Song, MD, Mi-Jeong Kim, MD, Sung-Cheol Yun, PhD,
Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer  Mian Xie, MD, PhD, Li Zhang, MD, Chao-Sheng He, MD, Jin-Hui Hou, MD,
Molecular Characterization of Urothelial Carcinoma of the Bladder and Upper Urinary Tract  Ji Yun Lee, Kyung Kim, Hyun Hwan Sung, Hwang Gyun Jeon, Byong.
The BIM Deletion Polymorphism and its Clinical Implication in Patients with EGFR- Mutant Non–Small-Cell Lung Cancer Treated with EGFR Tyrosine Kinase Inhibitors 
Clinical Characteristics and Prognostic Factors of Primary Pulmonary Vein Stenosis or Atresia in Children  Mi Kyoung Song, MD, Eun Jung Bae, MD, Soo In.
Outcome of 200 patients after an extracardiac Fontan procedure
Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.
Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 
Incidence of Brain Metastasis at the Initial Diagnosis of Lung Squamous Cell Carcinoma on the Basis of Stage, Excluding Brain Metastasis  Hyun Lee, MD,
The Presence of Mutations in Epidermal Growth Factor Receptor Gene Is Not a Prognostic Factor for Long-Term Outcome after Surgical Resection of Non–Small-Cell.
P2-090: Expression of cellular retinol binding protein-1 is associated with poor prognosis of stage I non-small cell lung cancer  Moo Suk Park, Yoon Soo.
A Functional Polymorphism in CSF1R Gene Is a Novel Susceptibility Marker for Lung Cancer among Never-Smoking Females  Hyo-Gyoung Kang, PhD, Shin Yup Lee,
The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non–small cell lung cancer  Kyong-Ah Yoon,
First-Line Gefitinib Treatment for Patients with Advanced Non-small Cell Lung Cancer with Poor Performance Status  Young Joo Lee, MD, Heung Tae Kim, MD,
Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.
P Is It Necessary to Repeat Lung Cancer Screening with Low-Dose CT(LDCT) in Female Never Smokers?  Hyae Young Kim, Kyu-Won Jung, Kun Young Lim,
Erlotinib Monotherapy for Stage IIIB/IV Non-small Cell Lung Cancer: A Multicenter Trial by the Korean Cancer Study Group  Ji Eun Uhm, MD, MSc, Byeong-Bae.
Role of CT and PET Imaging in Predicting Tumor Recurrence and Survival in Patients with Lung Adenocarcinoma  Ho Yun Lee, MD, PhD, So Won Lee, MD, Kyung.
Imaging Phenotyping Using Radiomics to Predict Micropapillary Pattern within Lung Adenocarcinoma  So Hee Song, MD, Hyunjin Park, PhD, Geewon Lee, MD,
Febuxostat in Hyperuricemic Patients With Advanced CKD
Preoperative left atrial volume index is a predictor of successful sinus rhythm restoration and maintenance after the maze operation  Yong Hoon Kim, MD,
The Applicability of the Proposed IASLC Staging Revisions to Small Cell Lung Cancer (SCLC) with Comparison to the Current UICC 6th TNM Edition  Sai-Hong.
Management of dilated ascending aorta during aortic valve replacement: Valve replacement alone versus aorta wrapping versus aorta replacement  Seung Hyun.
Clinical Outcomes and Prognosis of Recurrent Thymoma Management
Tumor-Infiltrating Foxp3+ Regulatory T Cells are Correlated with Cyclooxygenase-2 Expression and are Associated with Recurrence in Resected Non-small.
PD-L1 as a Companion Biomarker for Immune Checkpoint Inhibitors in NSCLC: Should RNA ISH (RISH) Be Considered?  Steven G. Gray, PhD  Journal of Thoracic.
High MET Gene Copy Number Leads to Shorter Survival in Patients with Non-small Cell Lung Cancer  Heounjeong Go, MD, Yoon Kyung Jeon, MD, PhD, Hyo Jin.
Role of CT and PET Imaging in Predicting Tumor Recurrence and Survival in Patients with Lung Adenocarcinoma  Ho Yun Lee, MD, PhD, So Won Lee, MD, Kyung.
Daniel Morgensztern, MD, Boone Goodgame, MD, Maria Q
Salvage Esophagectomy for Locoregional Failure After Chemoradiotherapy in Patients With Advanced Esophageal Cancer  Changhoon Yoo, MD, Ji Hyun Park, MD,
Outcomes of Mediastinoscopy and Surgery with or without Neoadjuvant Therapy in Patients with Non-small Cell Lung Cancer Who are N2 Negative on Positron.
Value of Combined Interpretation of Computed Tomography Response and Positron Emission Tomography Response for Prediction of Prognosis After Neoadjuvant.
Analysis of Tumor Markers in the Cytological Fluid Obtained from Computed Tomography-Guided Needle Aspiration Biopsy for the Diagnosis of Non-small Cell.
Association Between Asthma and Depression: A National Cohort Study
Management of Ground-Glass Opacity Lesions Detected in Patients with Otherwise Operable Non-small Cell Lung Cancer  Hong Kwan Kim, MD, Yong Soo Choi,
A Case of Pemetrexed-Induced Acute Lung Injury in Non-small Cell Lung Cancer  Hye Ok Kim, MD, Sung Yong Lee, MD, PhD, Jae Jeong Shim, MD, PhD, Kyung Ho.
Role of Postoperative Radiotherapy in Nonlocalized Thymoma
Endobronchial Ultrasound versus Mediastinoscopy for Mediastinal Nodal Staging of Non–Small-Cell Lung Cancer  Sang-Won Um, MD, PhD, Hong Kwan Kim, MD,
Impact of Chronic Obstructive Pulmonary Disease on the Mortality of Patients with Non– Small-Cell Lung Cancer  Seung Jun Lee, MD, Jinwoo Lee, MD, Young.
T4 or MI? Journal of Thoracic Oncology Volume 6, Issue 3, (March 2011)
Comparison of Neoadjuvant Chemotherapy Followed by Surgery to Upfront Surgery for Thymic Malignancy  Samina Park, MD, In Kyu Park, MD, PhD, Young Tae.
Association Between Age at Diagnosis and the Presence of EGFR Mutations in Female Patients with Resected Non-small Cell Lung Cancer  Yoon Hee Choi, MD,
Analysis of Treatment Outcomes of Intraventricular Chemotherapy in 105 Patients for Leptomeningeal Carcinomatosis from Non–Small-Cell Lung Cancer  Ho-Shin.
Early Intrapulmonary Recurrence After Pulmonary Metastasectomy Related to Colorectal Cancer  Mi Ri Hwang, MD, Ji Won Park, MD, Dae Yong Kim, MD, Hee Jin.
Genetic Polymorphisms in the Polycomb Group Gene EZH2 and the Risk of Lung Cancer  Kyong-Ah Yoon, MD, Hye Jin Gil, MS, Jihye Han, MS, Jaehee Park, MS,
False-Positive FDG-PET and Bronchial Anthracofibrosis
Prognostic Significance of CT-Determined Sarcopenia in Patients with Small-Cell Lung Cancer  Eun Young Kim, MD, Young Saing Kim, MD, Inkeun Park, MD,
Validity of International Association for the Study of Lung Cancer Proposals for the Revision of N Descriptors in Lung Cancer  Jin Gu Lee, MD, Chang Young.
APLCC POSTER SESSION 2 - WEDNESDAY, NOVEMBER 28
Prognostic implication of aberrant promoter hypermethylation of CpG islands in adenocarcinoma of the lung  Young Tae Kim, MD, PhD, Sun Jung Park, MS,
Long-Term Follow-Up of Ground-Glass Nodules After 5 Years of Stability
A Functional Polymorphism on Chromosome 15q25 Associated with Survival of Early Stage Non–Small-Cell Lung Cancer  Guang Jin, MD, PhD, Eun Young Bae, BS,
Stage III Thymic Epithelial Neoplasms are Not Homogeneous with Regard to Clinical, Pathological, and Prognostic Features  Min-Woong Kang, MD, PhD, Eung-Sirk.
Randomized Phase II Study of Maintenance Irinotecan Therapy Versus Observation Following Induction Chemotherapy with Irinotecan and Cisplatin in Extensive.
Effect of Tumor Size on Prognosis in Patients Treated with Radical Radiotherapy or Chemoradiotherapy for Non–Small Cell Lung Cancer: An Analysis of the.
Sleeve Lobectomy as an Alternative Procedure to Pneumonectomy for Non-small Cell Lung Cancer  Joon Suk Park, MD, Hee Chul Yang, MD, Hong Kwan Kim, MD,
MiR-1254 and miR-574-5p: Serum-Based microRNA Biomarkers for Early-Stage Non- small Cell Lung Cancer  Kristen M. Foss, BS, Chao Sima, PhD, Donatella Ugolini,
Presentation transcript:

Association between Genetic Variants in Pre-MicroRNAs and Survival of Early-Stage NSCLC  Mi Jeong Hong, MS, Yi Young Choi, MS, Ji-Ae Jang, MS, Hye-Jin Jung, MS, Shin Yup Lee, MD, PhD, Won Kee Lee, PhD, Seung Soo Yoo, MD, Jaehee Lee, MD, Seung Ick Cha, MD, PhD, Chang Ho Kim, MD, PhD, Eungbae Lee, MD, PhD, Hyo-Sung Jeon, PhD, Ji Woong Son, MD, Jae Yong Park, MD, PhD  Journal of Thoracic Oncology  Volume 8, Issue 6, Pages 703-710 (June 2013) DOI: 10.1097/JTO.0b013e318288dc0a Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 1 Overall survival and disease-free survival curves according to genotypes: (A) pre-miR-149 rs2292832 TC or CC vs. TT genotype; (B) pre-miR-196a rs11614913 CT or TT vs. CC genotype, and (C) the combined genotypes of the two polymorphisms (1 and 2 good genotypes vs. none of good genotypes). p values in the multivariate Cox hazard models. Journal of Thoracic Oncology 2013 8, 703-710DOI: (10.1097/JTO.0b013e318288dc0a) Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 2 Effect of the rs2292832T>C genotypes on miR-149 expression. Glyceraldehyde 3-phosphate dehydrogenase and the small nuclear RNA U6 were used to normalize the expression of primary and mature miR-149, respectively. (A) Expression levels of primary and mature miR-149 in tumors and normal lung tissues. Expression levels of primary and mature forms of miR-149 by the rs2292832T>C genotypes in normal lung tissues (B) and tumor tissues (C). Data represent median and quartiles. *p = 0.02, **p = 0.01. Journal of Thoracic Oncology 2013 8, 703-710DOI: (10.1097/JTO.0b013e318288dc0a) Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions